BIOMX LTD

General Data

supplementary funding
Reg Number
515220556
Sector
Biomed
Established
2015
No. of Employees
65
Stage
R&D
Additional Funding
1

Description

BiomX is developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis.

Technology

BiomX is developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Targeted Customers

Therapeutics Companies, Physicians, Dermatologists, Pulmonologists.

Management personnel

Michael Oster - CEO
[email protected]
Marina Wolfson - CFO
[email protected]

Contact information

Name
Jonathan Solomon
Email
[email protected]
Phone
0523945934
Website
http://www.biomx.com
Country
Israel
Zip
7414003

Tags

Artificial IntelligenceBiotechnologyComputational BiologyDeep TechHealthtechLife SciencesMedTechPharmaceuticalsSynthetic BiologyTherapeutics

Classified Technologies

Biomedicine and pharmaceuticals

Winning details

Route name
Winning year

R&D Program second/third year request for Entitled Growth Corporate
R&D Program second/third year request for Entitled Growth Corporate
2023
Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2024
Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2025
To the full list